Question 1

What are the potential benefits of participating in this trial for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) clinical trial (NCT06659640). Contact the study team or your healthcare provider for specific answers.

Question 2

How does ALN-6400 compare to other treatments currently available for HHT?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) clinical trial (NCT06659640). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from ALN-6400?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) clinical trial (NCT06659640). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) clinical trial (NCT06659640). Contact the study team or your healthcare provider for specific answers.

Question 5

What are the requirements regarding contraception during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) clinical trial (NCT06659640). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) clinical trial (NCT06659640). Contact the study team or your healthcare provider for specific answers.

What this study is about